Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00534521 · ClinicalTrials.gov registry record · Phase 3
Posterior Tibial Nerve Stimulation vs. Sham
A Phase 3 study, sponsored by Corewell Health East.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00534521: Completed Phase 3 study, sponsored by Corewell Health East.
NCT00534521 is a Phase 3 study that has completed, run by Corewell Health East. The registered enrollment target is 30 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00534521, a Phase 3 study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The overall goal of this research is to determine the efficacy of a sham for posterior tibial nerve stimulation (PTNS). This novel design is needed in order to have a sham treatment that is similar to the actual treatment. The PTNS is used to treat urgency and frequency in people with overactive bladder (OAB). Until research is done using a sham component, we are unable to ascertain if the current use of PTNS is due to a placebo effect.
Interventions
- DEVICE Sham
- DEVICE Posterior Tibial Nerve Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
What the finished NCT00534521 record still lists
NCT00534521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT00534521 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00534521 about?
NCT00534521 is a clinical study titled "Posterior Tibial Nerve Stimulation vs. Sham". The overall goal of this research is to determine the efficacy of a sham for posterior tibial nerve stimulation (PTNS). This novel design is needed in order to have a sham treatment that is similar to the actual treatment. The PTNS is used to treat urgency and frequency in people with overactive bla...
What is the current status of trial NCT00534521?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2007-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00534521?
The interventions under investigation include: Sham (DEVICE), Posterior Tibial Nerve Device (DEVICE).
Who is sponsoring clinical trial NCT00534521?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00534521's enrollment target sits among peer trials
30 1917th of 2000 higher than 68 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia